Evidence map›Paper›PMID 26616146›Full record

ArticleBiomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals2015

A Japanese cross-sectional multicentre study of biomarkers associated with cardiovascular disease in smokers and non-smokers.

Frank Lüdicke, John Magnette, Gizelle Baker, Rolf Weitkunat

Registry-linked trialOpen access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02103751 (A Multi-center Study to Determine the Levels of Biomarkers of Potential Harm and Biomarkers of Exposure to Cigarette Smoke in Asian Adult Smokers and Non-smokers), which is not on this map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02103751 completednot on this map

A Multi-center Study to Determine the Levels of Biomarkers of Potential Harm and Biomarkers of Exposure to Cigarette Smoke in Asian Adult Smokers and Non-smokers

TypeobservationalSponsorPhilip Morris Products S.A.Ran2007 to 2008Enrolled1,069ConditionsSmoking, Healthy
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Article
  5. Article
  6. Biomarkers of Inflammation and Oxidative Stress among Adult Former Smoker, Current E-Cigarette Users-Results from Wave 1 PATH Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Frank Lüdickea Philip Morris Products S.A., Research & Development , Neuchatel , Switzerland.
John Magnettea Philip Morris Products S.A., Research & Development , Neuchatel , Switzerland.
Gizelle Bakera Philip Morris Products S.A., Research & Development , Neuchatel , Switzerland.
Rolf Weitkunata Philip Morris Products S.A., Research & Development , Neuchatel , Switzerland.
Philip Morris International (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We performed a cross-sectional, multicentre study in Japan to detect the differences in biomarkers of exposure and cardiovascular biomarkers between smokers and non-smokers. Several clinically relevant cardiovascular biomarkers differed significantly between smokers and non-smokers, including lipid metabolism (high-density lipoprotein cholesterol concentrations - lower in smokers), inflammation (fibrinogen and white blood cell count - both higher in smokers), oxidative stress (8-epi-prostaglandin F2α - higher in smokers) and platelet activation (11-dehydro-thromboxane B2 - higher in smokers) (p ≤ 0.0001). These results provide further evidence showing that cardiovascular biomarkers can discriminate smokers from non-smokers, and could be used to evaluate the risks associated with tobacco products.

Indexed as

AdultAgedAged, 80 and overAnalysis of VarianceAsian PeopleBiomarkersCardiovascular DiseasesCholesterol, HDLCotinineC-Reactive ProteinCross-Sectional StudiesDinoprostFemaleFibrinogenHumansJapan11-dehydro-thromboxane B28-epi-prostaglandin F2alphaBiomarkersCholesterol, HDLCotinineC-Reactive ProteinDinoprostFibrinogenThromboxane B2Biomarkerscardiovascular diseasecigarettesJapansmoking

Identifiers

PMID26616146
PMCPMC4720051
OpenAlexW2188431903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.